AAAAAA
Results:
1-19
|
Results: 19
Authors:
SANGUINETI O
NOBILE MT
CHIARA S
BARZACCHI MC
GOZZA A
SIMONI C
FORNO GB
MUROLO C
ORSATTI M
SCARPATI D
VITALE V
MERLANO M
Citation: O. Sanguineti et al., A PHASE-II STUDY OF ALTERNATING CHEMORADIOTHERAPY IN THE TREATMENT OFESOPHAGEAL-CARCINOMA, Annals of oncology, 9, 1998, pp. 238-238
ADVANCED ESOPHAGEAL TUMOR - CHEMORADIOTHERAPY WITH ALTERNATING INFUSIONAL CISPLATINUM (DDP) AND 5 FU
Authors:
GRECCHI GL
LACIURA P
NUMICO G
DICOSTANZO G
PERRONI D
MERLANO M
Citation: Gl. Grecchi et al., ADVANCED ESOPHAGEAL TUMOR - CHEMORADIOTHERAPY WITH ALTERNATING INFUSIONAL CISPLATINUM (DDP) AND 5 FU, Annals of oncology, 9, 1998, pp. 244-244
Authors:
MERLANO M
MARCHETTI G
NUMICO G
DICOSTANZO G
RICCI I
CORVO R
SANGUINETI G
BENASSO M
Citation: M. Merlano et al., GEMCITABINE (GEM), CISPLATIN (CDDP) AND RADIOTHERAPY (RT) IN THE TREATMENT OF LOCALLY ADVANCED HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC) - A FEASIBILITY STUDY, Annals of oncology, 9, 1998, pp. 372-372
Authors:
RICCI I
SIMONI C
BENASSO M
BLENGIO F
NUMICO G
MARCECA F
MERLANO M
Citation: I. Ricci et al., IMPACT OF AGE ON RESPONSE RATE, COMPLIANCE, AND CLINICAL BEHAVIOR OF PATIENTS WITH RELAPSED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK TREATED WITH PALLIATIVE INTENT, Annals of oncology, 9, 1998, pp. 133-133
Authors:
MERLANO M
BENASSO M
NUMICO G
DANOVA M
SANTELLI A
AMELI F
BLENGIO F
RICCI I
ROSSO M
Citation: M. Merlano et al., 5-FLUOROURACIL DOSE INTENSIFICATION AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN CISPLATIN-BASED CHEMOTHERAPY FOR RELAPSED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-II STUDY, American journal of clinical oncology, 21(3), 1998, pp. 313-316
Authors:
NUMICO G
BENASSO M
VANNOZZI MO
MERLANO M
ROSSO R
VIALE M
ESPOSITO M
Citation: G. Numico et al., HYDRATION REGIMEN AND HEMATOLOGICAL TOXICITY OF A CISPLATIN-BASED CHEMOTHERAPY REGIMEN - CLINICAL OBSERVATIONS AND PHARMACOKINETIC ANALYSIS, Anticancer research, 18(2B), 1998, pp. 1313-1318
Authors:
CORVO R
GIARETTI W
SANGUINETI G
GEIDO E
BACIGALUPO A
ORECCHIA R
BENASSO M
NUMICO GM
MERLANO M
MARGARINO G
VITALE V
Citation: R. Corvo et al., CHEMORADIOTHERAPY AS AN ALTERNATIVE TO RADIOTHERAPY ALONE IN FAST PROLIFERATING HEAD AND NECK SQUAMOUS-CELL CARCINOMAS, Clinical cancer research, 3(11), 1997, pp. 1993-1997
Authors:
BENASSO M
NUMICO G
MERLANO M
Citation: M. Benasso et al., CARBOPLATIN AND 5-FLUOROURACIL IN SQUAMOUS-CELL CARCINOMA OF THE HEADAND NECK PREVIOUSLY RESPONDING TO CISPLATIN AND 5-FLUOROURACIL, European journal of cancer, 33(2), 1997, pp. 318-319
Authors:
BENASSO M
BONELLI L
NUMICO G
CORVO R
SANGUINETI C
ROSSO R
VITALE V
MERLANO M
Citation: M. Benasso et al., TREATMENT WITH CISPLATIN AND FLUOROURACIL ALTERNATING WITH RADIATION FAVORABLY AFFECTS PROGNOSIS OF INOPERABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - RESULTS OF A MULTIVARIATE-ANALYSIS ON 273 PATIENTS, Annals of oncology, 8(8), 1997, pp. 773-779
Authors:
BENASSO M
NUMICO G
ROSSO R
MERLANO M
RICCI I
GENTILE A
Citation: M. Benasso et al., CHEMOTHERAPY FOR RELAPSED HEAD AND NECK-CANCER - PACLITAXEL, CISPLATIN, AND 5-FLUOROURACIL IN CHEMOTHERAPY-NAIVE PATIENTS - A DOSE-FINDING STUDY, Seminars in oncology, 24(6), 1997, pp. 46-50
Authors:
MERLANO M
BENASSO M
CORVO R
ROSSO R
VITALE V
BLENGIO F
NUMICO G
MARGARINO G
BONELLI L
SANTI L
Citation: M. Merlano et al., 5-YEAR UPDATE OF A RANDOMIZED TRIAL OF ALTERNATING RADIOTHERAPY AND CHEMOTHERAPY COMPARED WITH RADIOTHERAPY ALONE IN TREATMENT OF UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Journal of the National Cancer Institute, 88(9), 1996, pp. 583-589
Authors:
MERLANO M
Citation: M. Merlano, 5-YEAR UPDATE OF A RANDOMIZED TRIAL OF ALTERNATING RADIOTHERAPY AND CHEMOTHERAPY COMPARED WITH RADIOTHERAPY ALONE IN TREATMENT OF UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - RESPONSE, Journal of the National Cancer Institute, 88(19), 1996, pp. 1407-1408
Authors:
MERLANO M
Citation: M. Merlano, CHEMOTHERAPY TRIALS IN HEAD AND NECK-CANCER, Head & neck, 17(3), 1995, pp. 266-267
Authors:
MERLANO M
BENASSO M
BLENGIO F
NUMICO G
Citation: M. Merlano et al., INTERACTION RT-CT - RATIONALE AND CLINICAL-EXPERIENCE IN HEAD AND NECK (HN) TUMORS, European journal of cancer, 31A, 1995, pp. 19-19
Authors:
BENASSO M
CORVO R
NUMICO G
CAVALLARI M
BLENGIO F
SANGUINETI G
ROSSO M
MERLANO M
Citation: M. Benasso et al., CONCOMITANT ADMINISTRATION OF 2 STANDARD REGIMENS OF CHEMOTHERAPY ANDRADIOTHERAPY IN ADVANCED SQUAMOUS CARCINOMA OF THE HEAD AND NECK - A FEASIBILITY STUDY, Anticancer research, 15(6B), 1995, pp. 2651-2654
Authors:
MERLANO M
BENASSO M
CAVALLARI M
BLENGIO F
ROSSO M
Citation: M. Merlano et al., CHEMOTHERAPY IN HEAD AND NECK-CANCER, European journal of cancer. Part B, Oral oncology, 30B(5), 1994, pp. 283-289
Authors:
COLELLA E
MERLANO M
BLENGIO F
ANGELINI F
CEFARO GPA
SCASSO F
LORUSSO V
CIRULLI S
GIANNARELLI D
COGNETTI F
Citation: E. Colella et al., RANDOMIZED PHASE-II STUDY OF METHOTREXATE (MTX) VERSUS METHOTREXATE PLUS LONIDAMINE (MTX+LND) IN RECURRENT AND OR METASTATIC CARCINOMA OF THE HEAD AND NECK/, European journal of cancer, 30A(7), 1994, pp. 928-930
Authors:
MERLANO M
BENASSO M
CAVALLARI M
BLENGIO F
SGUOTTI C
ROSSO M
ROSSO R
Citation: M. Merlano et al., INTENSIFIED CHEMOTHERAPY WITH GRANULOCYTE-MONOCYTE COLONY-STIMULATINGFACTOR PROTECTION IN ADVANCED, RELAPSED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-I STUDY, American journal of clinical oncology, 17(6), 1994, pp. 494-497
Authors:
BENASSO M
MERLANO M
BLENGIO F
CAVALLARI M
ROSSO R
TOMA S
Citation: M. Benasso et al., CONCOMITANT ALPHA-INTERFERON AND CHEMOTHERAPY IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, American journal of clinical oncology, 16(6), 1993, pp. 465-468
Risultati:
1-19
|